*Photo Credit: Twitter
Kevin Davies
Author, Cracking the Genome; Executive Editor, The CRISPR Journal; Founding Editor, Nature Genetics
SPEAKER FEE RANGE: Please Inquire
TRAVELS FROM: New York
RELATED TOPICS: Healthcare Expert, Tech Futurist
Kevin Davies, Ph.D., is the author of Cracking the Genome, an inside account of the race for the Human Genome Project hailed by one reviewer as “A rollicking good tale about an enduring intellectual monument.” His book, The $1000 Genome, details the revolution in personal medicine as individuals can affordably read their complete DNA sequence. Davies is currently the Editor-in-Chief of Bio-IT World, a monthly magazine covering technology in the life sciences, published by Cambridge Healthtech Institute. He is the founding editor of “Nature Genetics” and has also worked at the Howard Hughes Medical Institute and Cell Press. His presentation combines personal insight, humor, cutting-edge science and a gift for making the impact of 21st-century technology and genetic science accessible to a very broad audience.
Kevin Davies, Ph.D., is a British author and science writer who covers advances in genomics and personalized medicine, including gene editing.
Kevin is the author of books including Cracking the Genome, an inside account of the race for the Human Genome Project hailed by one reviewer as “A rollicking good tale about an enduring intellectual monument.” His book, The $1000 Genome, detailed the revolution in personalized medicine and next-generation genome sequencing. He is also the co-author of DNA: The Story of the Genetic Revolution (Knopf, 2017), with Nobel laureate James Watson.
Davies is currently the Executive Editor of The CRISPR Journal, He is the founding editor of Nature Genetics and former Editor-in-Chief at Cell Press. He also served as Editor-in-Chief of Bio-IT World, a magazine covering technology in the life sciences.
A frequent commentator on genome issues in print, television and radio, Davies has delivered engaging lectures on the Human Genome Project and its impact to diverse audiences around the world. Kevin is currently working on a new book on genome editing, supported by the award of a coveted Guggenheim Foundation Fellowship in 2017.
A graduate of Oxford University, Davies earned his PhD in genetics from St Mary’s hospital, University of London. He emigrated to the United States in 1987 to pursue postdoctoral research before moving into science publishing. He currently lives in the New York area.
Kevin is the author of books including Cracking the Genome, an inside account of the race for the Human Genome Project hailed by one reviewer as “A rollicking good tale about an enduring intellectual monument.” His book, The $1000 Genome, detailed the revolution in personalized medicine and next-generation genome sequencing. He is also the co-author of DNA: The Story of the Genetic Revolution (Knopf, 2017), with Nobel laureate James Watson.
Davies is currently the Executive Editor of The CRISPR Journal, He is the founding editor of Nature Genetics and former Editor-in-Chief at Cell Press. He also served as Editor-in-Chief of Bio-IT World, a magazine covering technology in the life sciences.
A frequent commentator on genome issues in print, television and radio, Davies has delivered engaging lectures on the Human Genome Project and its impact to diverse audiences around the world. Kevin is currently working on a new book on genome editing, supported by the award of a coveted Guggenheim Foundation Fellowship in 2017.
A graduate of Oxford University, Davies earned his PhD in genetics from St Mary’s hospital, University of London. He emigrated to the United States in 1987 to pursue postdoctoral research before moving into science publishing. He currently lives in the New York area.
- The Science and Ethics of #CRISPRbabies
- CRISPR and Genome Editing
- Personalized Medicine and Consumer Genomics
- Personalized Medicine and Consumer Genomics
- The Human Genome Project
- The $1000 Genome
We can help ideate, source and book speakers that aren't on our website, too. Leave an inquiry or call us at